FEATURED COMPANIES
- 3D Systems Corporation
- Exone
- Formlabs
- GE
- Materialise NV
- Organovo HoldingsInc.
The factors that drive the 3D printing healthcare market are reduction of errors, decrease in development cost & time, and the ability to build customized products. In addition, increase in scope of applications in healthcare and biomedical applications is expected to create lucrative growth opportunities. On the contrary, high cost of 3D printing and dearth of skilled labors hamper the growth of the market.
Furthermore, increase in healthcare expenditure and rise in collaborations between academic institutions, hospitals, and companies supplement the market growth. However, unfavorable reimbursement policies hinders the market growth. Conversely, emerging economies such as India, China, Mexico, Brazil, and others are anticipated to provide new opportunities for the market growth during the forecast period.
The global 3D printing healthcare market is segmented into component, technology, application, end user, and region. By component, the market is segregated into system/device, materials, and services. Depending on technology, it is categorized into droplet deposition (DD), photopolymerization, laser beam melting, electronic beam melting (EBM), and laminated object manufacturing. The applications covered in the study include external wearable devices, clinical study devices, implants, and tissue engineering. As per end user, the market is fragmented into medical & surgical centers, pharma & biotech companies, and academic institutions. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report highlights the market dynamics to understand the global 3D printing healthcare market and capitalize on the prevailing opportunities.
- Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
- Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
- Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
By Component
o System/Device
o Materials
o Services
By Technology
o Droplet Deposition (DD)
- Fused Deposition Modeling (FDM) Technology
- Low-temperature Deposition Manufacturing (LDM)
- Multiphase Jet Solidification (MJS)
- Stereolithography (SLA)
- Continuous Liquid Interface Production (CLIP)
- Two-Photon Polymerization (2PP)
- Selective Laser Sintering (SLS)
- Selective Laser Melting (SLM)
- Direct Metal Laser Sintering (DMLS)
o Laminated Object Manufacturing
By Application
o External Wearable Devices
o Clinical Study Devices
o Implants
o Tissue Engineering
By End User
o Medical & Surgical Centers
o Pharmaceutical & Biotechnology Companies
o Academic Institutions
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- 3D Systems Corporation
- Exone
- Formlabs
- GE
- Materialise NV
- Oxferd Performance Materials, Inc.
- Organovo Holdings, Inc.
- Proto Labs
- SLM Solutions Group AG
- Stratasys Ltd.
The other players in the value chain include (profiles not included in the report):
- Advanced Solutions Life Sciences
- Aspect Biosystem
- Cyfuse Biomedical K.K.
- Envisiontec
- Nano Dimension
What is the estimated value of the Global 3D Printing Healthcare Market?
What is the growth rate of the Global 3D Printing Healthcare Market?
What is the forecasted size of the Global 3D Printing Healthcare Market?
Who are the key companies in the Global 3D Printing Healthcare Market?
FEATURED COMPANIES
- 3D Systems Corporation
- Exone
- Formlabs
- GE
- Materialise NV
- Organovo HoldingsInc.
FEATURED COMPANIES
- 3D Systems Corporation
- Exone
- Formlabs
- GE
- Materialise NV
- Organovo HoldingsInc.
Additive manufacturing, alternately known as 3D printing, refers to a layer-by-layer addition technique of producing a three-dimensional physical object process by using digital 3D design data through a computer aided design (CAD) package. The global 3D printing healthcare market has witnessed dynamic growth in the recent years, owing to rapid technological advancements, increase in investments in R&D activities, and rapid expansion of customer base. Furthermore, the customizations offered by this technology, increase in scope of biomedical applications, efficient material usage, and reduction in cost & time are the major factors supplementing the growth of the market. In addition, the utilization of 3D printing technology in the healthcare sector is anticipated to facilitate effective pre-operative planning, better surgeon practice, enhanced patient outcomes, and suitable alternative to animal testing.
Alternatively, high cost associated with 3D printers, copyright & patent infringement concerns, lack of quality & regulatory frameworks for 3D printers, reimbursement challenges, and concerns regarding mechanical properties & biocompatibility are the key factors responsible for hampering the market growth. Moreover, inadequate technical know-how in developing economies impedes the market growth.
The global 3D printing healthcare market is segmented based on component, technology, application, end user, and region. Depending on component, the market is categorized into systems, software, and services. On the basis of technology, it is segregated into droplet deposition, photopolymerization, laser beam melting, electronic beam melting, laminated object manufacturing, and others.
The applications covered in the study include external wearable devices, implants, clinical study devices, and tissue engineering. The end users of the market comprise medical & surgical centers, pharmaceutical & biotechnology companies, and academic institutions.
The system segment dominated the global 3D printing healthcare market by garnering for more than 50% of share in 2018.
This is majorly attributed to increase in adoption rate of 3D products, advancements in 3D technology, augmented investments in R&D activities for advancement in 3D printers, rapid expansion of the customer base, and increase in biomedical applications. However, the materials segment is anticipated to emerge as a lucrative segment, owing to increase in adoption of 3D systems and rise in utilization of 3D printing technology. The advent of portable and energy-efficient 3D printers are further expected to propel the market growth.
In 2018, the external wearable devices segment led the global market, owing to the presence of large patient pool, liberalization of regulations for 3D printers, increase in adoption of 3D printing technology in dental clinics & hospitals, and customizations.
North America was the highest revenue generator in 2018 due to widespread adoption of 3D printing technology and numerous collaborations between academic and commercial organizations.
Furthermore, the region is anticipated to continue to dominate the global market during the forecast period, owing to technological innovations pertaining to 3D printing, increase in funding for advancement in 3D printers for healthcare, and upsurge in patient pool. In addition, the increase in number of end users has fueled the adoption rate of this technology. However, the Asia-Pacific region is expected to register the highest growth rate during the forecast period. This is attributed to funding received by various start-up companies to introduce advanced 3D printers, escalated demand for advanced medical facilities, and increased healthcare expenditure.
Key Findings of the 3D Printing Healthcare Market :
The 3D healthcare services segment is projected to exhibit the highest CAGR during the forecast period.
Polymers are the most preferred materials for 3D printing, as they account for about half of the market revenue in the materials market; whereas, the ceramics segment is projected as the fastest growing segment during the forecast period.
The electron beam melting technology segment is projected to grow at the highest from 2019 to 2026.
The medical and surgical centers end user segment accounts for two-thirds of the market and are expected to dominate the market until 2026.
The tissue engineering application segment would emerge as the fastest growing segment during the forecast period.
North America accounted for two-fifths share of the healthcare 3D printing market, whereas the Asia-Pacific is anticipated to be the fastest growing market, from 2019 to 2026.
The key developmental strategies adopted by leading market players are product launches, collaborations, and partnerships. The prominent market players profiled in this report include 3D Systems Corporation, Exone, Formlabs, GE, Materialise NV, Oxferd Performance Materials, Inc., Organovo Holdings, Inc., Proto Labs, SLM Solutions Group AG, and Stratasys Ltd.
The other players in the value chain include Advanced Solutions Life Sciences, Aspect Biosystem, Cyfuse Biomedical K.K., Envisiontec, and Nano Dimension.
- 3D Systems Corporation
- Exone
- Formlabs
- GE
- Materialise NV
- Oxferd Performance Materials Inc.
- Organovo HoldingsInc.
- Proto Labs
- SLM Solutions Group AG
- Stratasys Ltd.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...